Boric Acid

Boric Acid

SCHEMBL28327201

CN(C)CCCc1ccc(OC(C)(C)C(C)(C)O)cn1.OB(O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 3/20 0.35
▸ KDM4E B2RXH2 5/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ SCN1A P35498 1/20 0.32
▸ SCN2A Q99250 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ SCN3A Q9NY46 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ LSS P48449 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30839665 0.79 HRH3 (0.40) HRH3KDM4EALDH1A1SMN1; SMN2NOS3
SCHEMBL21541905 0.79 HRH3 (0.40) HRH3KDM4EALDH1A1SMN1; SMN2NOS3
Boric Acid SCHEMBL27923833 0.72 — —
SCHEMBL21541768 0.71 CXCR1 (0.39) HRH3NOS3NOS1NOS2
Boric Acid SCHEMBL28085810 0.69 SLC2A1 (0.42) KDM4EALDH1A1SMN1; SMN2TDP1CYP3A4
Boric Acid SCHEMBL27988681 0.67 — —
SCHEMBL15067149 0.66 RXFP1 (0.52) ALDH1A1SMN1; SMN2LMNA
Boric Acid SCHEMBL27995448 0.64 CA1 (0.49) KDM4EALDH1A1SMN1; SMN2LMNACYP3A4
SCHEMBL19959050 0.64 KCNH2 (0.37) HRH3CYP2D6CYP3A4CYP2C9
SCHEMBL15067284 0.64 ATM (0.40) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110312717-A The condensed heteroaryl tricyclic compound replaced is as kinase inhibitor and its application 上海瑛派药业有限公司 2019-10-08 — — CN disclosed
Send feedback